ALK-positive Large B-cell Lymphoma: A Clinicopathologic Retrospective Descriptive Study from a Tertiary Care Cancer Centre in India
Introduction: Anaplastic Lymphoma Kinase (ALK) positive Large B-Cell Lymphoma (ALK+ LBCL) is a very rare aggressive B-cell lymphoma presenting significant diagnostic challenges due to their rarity and unique immunophenotypic features. ALK is a tyrosine kinase receptor and is expressed by ALK+ LBCL d...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
JCDR Research and Publications Private Limited
2023-06-01
|
| Cyfres: | Journal of Clinical and Diagnostic Research |
| Pynciau: | |
| Mynediad Ar-lein: | https://jcdr.net/articles/PDF/18104/62619_CE[Ra1]_F(IS)_PF1(HB_SHU_KM)_PFA(HB_KM)_PN(KM).pdf |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|